When breast cancer does occur among this population, those with BRCA1 mutations are more likely to be diagnosed with triple-negative breast cancer, associated with higher risk of mortality5, while BRCA2-positive women are more likely to be diagnosed with hormone receptor-positive tumors6. Here, BRCA1 is linked to breast carcinoma.